| Serial Number | 97187298 |
| Word Mark | S |
| Filing Date | Thursday, December 23, 2021 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, April 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 22, 2023 |
| Description of Mark | The mark consists of a stylized S in the shape of a swan's wing. |
| Goods and Services | Therapeutic pharmaceutical compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapy, namely, gene inhibition therapy and/or RNA interference (RNAi), for the treatment of genetic diseases and disorders and neurological diseases and disorders; therapeutic pharmaceutical compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapy, namely, gene augmentation therapy, for the treatment of genetic diseases and disorders and neurological diseases and disorders; therapeutic pharmaceutical compositions comprised of adeno-associated viral (AAV) vectors and recombinant adeno-associated viral (rAAV) vectors for therapeutic effect in gene therapies using intrathecal administration, for the treatment of genetic diseases and disorders and neurological diseases and disorders; biologic preparations for use in the treatment of genetically based diseases and disorders; biologic preparations for medical purposes, namely, for gene therapy for treating genetic disorders; pharmaceutical preparations that modulate RNA expression for the treatment of neurological diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals for the treatment of genetic diseases and disorders and neurological diseases and disorders; pharmaceutical preparations for gene therapy, gene inhibition and gene augmentation, for the treatment of genetic diseases and disorders and neurological diseases and disorders; viruses, viral vectors and viral constructs, all in the nature of pharmaceutical preparations, for the treatment of neurological diseases and disorders and genetic diseases and disorders; pharmaceutical preparations for gene therapy, for the treatment of genetic diseases and disorders and neurological diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of genetic disorders and neurological diseases and disorders; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders and neurological diseases and disorders; pharmaceutical preparations, namely, DNA and/or RNA therapeutics for the treatment of genetic disorders and neurological diseases and disorders |
| Goods and Services | Development of pharmaceutical preparations for use in gene therapy; genetic engineering and biotechnology research; research and development of new products in the field of gene therapeutics; scientific and medical research in the field of genetics, gene therapy and genetic engineering; laboratory research in the fields of genetics, gene therapy, drug development, biotechnology, microbiology and molecular biology; pharmaceutical drug discovery; scientific research in the field of gene therapy discovery; drug development and therapeutic drug development; genetic drug development and therapeutic drug development; biological research; biological drug development and scientific research in the field of biological development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 14, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, March 15, 2021 |
| First Use In Commerce Date | Monday, March 15, 2021 |
| Party Name | SwanBio Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Bala Cynwyd, PA 19004 |
| Party Name | SwanBio Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Bala Cynwyd, PA 19004 |
| Event Date | Event Description |
| Friday, April 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 11, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, April 11, 2024 | SOU EXTENSION 1 FILED |
| Thursday, April 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 17, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 29, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 29, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, May 19, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, May 19, 2023 | FINAL REFUSAL E-MAILED |
| Friday, May 19, 2023 | FINAL REFUSAL WRITTEN |
| Monday, April 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 10, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 12, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 12, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 12, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 27, 2022 | ASSIGNED TO EXAMINER |
| Saturday, January 15, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, January 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |